The advancements in cardiovascular regenerative medicine are reshaping therapeutic strategies for heart diseases by promoting tissue repair and regeneration. This innovative field leverages technologies such as induced pluripotent stem cells and growth factor delivery to restore the heart’s structural and functional integrity. Bioengineered scaffolds and 3D bioprinting are also being utilized to reconstruct damaged myocardium and improve vascularization. Researchers are further exploring the role of exosomes and microRNAs in enhancing the heart’s natural regenerative processes. With ongoing clinical trials and interdisciplinary collaboration, cardiovascular regenerative medicine holds immense potential to provide long-term solutions for conditions like ischemic heart disease and heart failure, moving beyond traditional treatments toward curative approaches.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation